daprodustat Archives -

GlaxoSmithKline says the FDA has started its review of daprodustat for anaemia associated with chronic kidney disease (CKD),

GSK goes for gold as FDA starts review of daprodustat

https://pharmaphorum.com/news/fda-starts-review-of-gsks-kidney-drug-daprodustat/

The EU regulator has approved FibroGen and Astellas Evrenzo for adults with anaemia caused by chronic kidney disease

After FDA snub, EMA backs FibroGen, Astellas’ roxadustat

https://pharmaphorum.com/news/after-fda-snub-ema-backs-fibrogen-astellas-roxadustat/

The FDA has demanded another clinical trial of FibroGen and AstraZeneca’s roxadustat for anaemia caused by chronic kidney

FDA rejects FibroGen/AZ’s roxadustat, asking for new trial

https://pharmaphorum.com/news/fda-rejects-fibrogen-azs-roxadustat-asking-for-new-trial/

Safety concerns seem to have scuppered any hope of a near-term approval for FibroGen and AstraZeneca’s roxadustat for

FDA adcomm turns down FibroGen, AZ’s roxadustat for CKD anaemia

https://pharmaphorum.com/news/fda-adcomm-turns-down-fibrogen-azs-roxadustat-for-ckd-anaemia/

Astellas has its first approval for roxadustat, getting a green light in Japan for the drug as a

Astellas gets nod in Japan for roxadustat, ahead of GSK rival

https://pharmaphorum.com/news/astellas-gets-nod-in-japan-for-roxadustat-ahead-of-gsk-rival/

daprodustat